Cargando…
Doxorubicin-loaded red blood cells reduced cardiac toxicity and preserved anticancer activity
Doxorubicin (DOX) is one of the most widely used anticancer agents. DOX is known for inducing cardiotoxicity, resulting in the long-term development of heart failure. Intravascular delivery of DOX may benefit from the carriage by red blood cells (RBCs), as they can limit the systemic toxicity while...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450495/ https://www.ncbi.nlm.nih.gov/pubmed/30929538 http://dx.doi.org/10.1080/10717544.2019.1591544 |